Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001013762-25-002278·PSYENCE BIOMEDICAL LTD.
Schedule 13D ownership disclosure
PSYENCE BIOMEDICAL LTD
Common Shares, without par value · CUSIP: 74449F209
Event date: 2025-03-25
- Filing-level shares
- 678,722.00
- Percent of class
- 14.99%
- Psyence Group Inc.Reported CIK 0002009573
Shares: 678,722.00 · Class: 14.99%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001013762-25-002278
- Form type
- SCHEDULE 13D/A
- Filer
- PSYENCE BIOMEDICAL LTD.
- CIK
- CIK 1985062
- Filed
- Mar 25, 2025
- Reporting period
- Mar 25, 2025
- Description
- Schedule 13D beneficial ownership